Who Is Really Driving Up Insulin Costs?

A recently approved bill in the House, currently being deliberated in the Senate, sets a limit of $35 per month for insulin payments for individuals covered by Medicare or private health insurance. While the legislation directly addresses the affordability crisis of this life-saving medicine, its long-term impact appears to be more of a reshuffling of the deck rather than a fundamental change in the game of insulin costs.

Hello! My channel is about me being on the lookout for interesting old and new articles, and transforming them into videos. If you like this kind of content, subscribe. If not, skip it!